We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Air Filter with `Catch and Kill` Technology Eliminates Airborne Viruses, Including COVID-19 Variants

By HospiMedica International staff writers
Posted on 07 Jan 2022
Print article
Image: Air Filter with `Catch and Kill` Technology (Photo courtesy of Integrated Viral Protection, LLC)
Image: Air Filter with `Catch and Kill` Technology (Photo courtesy of Integrated Viral Protection, LLC)

The only air filter in the world proven to "catch and kill" airborne COVID-19, Anthrax spores, bacteria, allergens, and other asthma triggers was launched at the 2022 Consumer Electronics Show (CES).

Integrated Viral Protection, LLC (Houston, TX, USA) demonstrated its scientifically proven technology with the release of its new Personal Air Filtration Unit to provide additional protection with the vaccine.

IVP allows breathing with confidence by changing the way air is cleaned. This patented technology, based on science, kills airborne viruses in a single pass, including sub-micron variants causing COVID-19, anthrax spores, allergens, and other harmful respiratory triggers. IVP units use a heated foam stainless steel mesh embedded inside a HEPA filter to kill airborne pathogens instantly and removing these pathogens from the air.

The FDA EUA approved Personal Air Filtration Unit was designed to reduce person-to-person virus transmission and is ideal for schools, office spaces, mass transit, and other small indoor spaces IVP's products have been deployed in businesses, health care facilities, schools, and homes around the globe, providing an extra layer of protection to keep indoor spaces safer.

"The time for action is now to combat this virus and its many mutations," said Monzer Hourani, inventor of IVP's indoor air protection system.

Related Links:
Integrated Viral Protection, LLC 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Medical Oxygen Analyzer
MAXO2+AE

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.